Finance

Lists
TNDM:NASDAQ
Tandem Diabetes Care Inc
$22.38
+19.11%
(+3.59) 1D
$22.27
-0.49% (-0.11)
After hours
Closed: Aug 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNDM...
Open
$17.39
High
$22.65
Low
$17.07
Mkt. cap
1.56B
Avg. vol.
1.92M
Volume
5.44M
52-wk high
$29.65
52-wk low
$10.00
EPS
-$1.40
Beta
1.54
Shares outstanding
68.53M
No. of employees
2K
Open
$17.39
High
$22.65
Low
$17.07
Mkt. cap
1.56B
Avg. vol.
1.92M
Volume
5.44M
52-wk high
$29.65
52-wk low
$10.00
EPS
-$1.40
Beta
1.54
Shares outstanding
68.53M
No. of employees
2K
News stories
From sources across the web
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors. Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com
Analyst ratings
Based on 16 analysts giving stock ratings to TNDM in the past 3 months
Buy
Buy
8
Hold
8
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TNDM in the last 3 months.
Highest
Current $22.38
$50.00 (+123.41%)
Average
$26.30 (+17.52%)
Lowest
$15.50 (-30.74%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Block
Stifel Nicolaus
Hold
Maintained
$22.00
-1.7%
08/07/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$50.00
+123.4%
08/07/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
$25.00
+11.7%
08/07/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$22.00
-1.7%
08/07/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$33.00
+47.5%
08/07/2026
Richard Newitter
Truist Financial
Buy
Reiterated
$31.00
+38.5%
08/07/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$40.00
+78.7%
08/07/2026
Danielle Antalffy
UBS
Hold
Reiterated
$18.00
-19.6%
08/07/2026
Joanne Wuensch
Citi
Hold
Maintained
$21.00
-6.2%
08/07/2026
Kendall Au
RBC Capital
Buy
Maintained
$26.00
+16.2%
08/06/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
$26.00
+16.2%
08/06/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$28.00
+25.1%
08/06/2026
David Roman
Goldman Sachs
Hold
Maintained
$16.00
-28.5%
07/14/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$20.00
-10.6%
07/15/2026
Kieran Ryan
Deutsche Bank
Hold
Initiated
$15.50
-30.7%
06/23/2026
Unknown Analyst
Deutsche Bank
Hold
Initiated
$15.50
-30.7%
06/23/2026
Larry Biegelsen
Wells Fargo
Buy
Upgraded
$27.00
+20.6%
06/01/2026
Bruce Jackson
Benchmark Co.
Hold
Initiated
-
-
05/11/2026
Matt Miksic
Barclays
Buy
Maintained
$55.00
+145.8%
05/08/2026
Issie Kirby
Rothschild & Co Redburn
Buy
Maintained
$45.00
+101.1%
04/24/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
$23.00
+2.8%
02/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
249.25M
290.38M
247.22M
254.56M
Cost of goods sold
114.96M
122.92M
110.43M
109.78M
Cost of revenue
114.96M
122.92M
110.43M
109.78M
Research and development expenses
47.92M
46.07M
46.04M
46.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.44M
113.10M
108.19M
111.64M
Operating expense
154.36M
159.17M
154.22M
158.57M
Total operating expenses
269.32M
282.09M
264.66M
268.35M
Operating income
-20.06M
8.29M
-17.43M
-13.79M
Other non operating income
9.00K
616.00K
26.00K
-
EBT including unusual items
-25.14M
4.68M
-19.88M
-20.66M
EBT excluding unusual items
-22.34M
4.68M
-19.88M
-20.66M
Income tax expense
-3.98M
5.27M
516.00K
510.00K
Effective tax rate
15.82%
112.58%
-2.60%
-2.47%
Other operating expenses
-
-
-
-
Net income
-21.16M
-589.00K
-20.39M
-21.17M
Net profit margin
-8.49%
-0.20%
-8.25%
-8.32%
Earnings per share
-0.31
-0.01
-0.30
-0.31
Interest and investment income
3.20M
2.80M
3.60M
1.22M
Interest expense
-2.06M
-2.08M
-2.20M
-2.45M
Net interest expenses
1.14M
725.00K
1.40M
-1.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.57M
12.79M
-12.93M
-9.32M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps